Hyperthermia cancer treatment market uses thermal therapy to treat cancer. It involves heating the targeted body area or organ using radiofrequency waves, microwaves, infrared light or ultrasound to damage and kill cancer cells or sensitize them to chemotherapy or radiation therapy. Some common types of hyperthermia used in cancer treatment include local hyperthermia to heat a specific area of the body containing cancer cells, regional hyperthermia to treat a larger area, and whole body hyperthermia to heat the entire body. It is mostly used along with chemotherapy and radiation therapy to make cancer cells more vulnerable.
The global hyperthermia cancer treatment market is estimated to be valued at US$ 187.05 billion in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growing geriatric population is expected to drive the hyperthermia cancer treatment market. Cancer incidence is strongly correlated with age, and 65% of all cancers are diagnosed in patients over 65 years old. According to the World Health Organization, the global population aged 60 years and older is expected to reach 2 billion by 2050. Advanced age implies weaker immune system and slower recovery from diseases like cancer. Hence, hyperthermia’s localized and non-invasive approach makes it suitable for elderly cancer patients. Furthermore, rising prevalence of cancer worldwide will also contribute to the market growth. According to WHO, global cancer burden rose to 19.3 million cases and 10 million cancer deaths in 2020. The continuously growing cancer pools increases the need for therapies like hyperthermia treatment.
Segment Analysis
The hyperthermia cancer treatment market can be segmented based on type into localized hyperthermia, regional hyperthermia and whole-body hyperthermia. The localized hyperthermia segment is dominating currently as it helps in targeting specific tumour sites by using heat applicators to treat and destroy cancer cells in that area while sparing surrounding healthy tissues. Regional hyperthermia treats larger areas that may have cancer affected lymph nodes surrounding the tumour site by using external or internal applicators.
PEST Analysis
Political: Regulations supporting research and funding for cancer treatments are driving the hyperthermia cancer treatment market. Some countries have formulated favorable reimbursement policies to increase affordability and access.
Economic: Rising healthcare spending and increasing disposable incomes are enabling more people to avail costly cancer treatments like hyperthermia. The growth in emerging economies presents new opportunities.
Social: Growing cancer incidence rates due to changing lifestyles and an aging population are major factors. Hyperthermia is more accepted now as an adjunct treatment that improves outcomes when combined with chemotherapy and radiotherapy.
Technological: Advancements in precision oncology, medical device miniaturization and warming techniques are expanding applications. Combined treatments that leverage thermal, radiation and immune therapies show promise.
Key Takeaways
The Global Hyperthermia Cancer Treatment Market Growth is expected to witness high growth over the forecast period supported by rising incidence, growing acceptability and technological advancements. Regional analysis shows that North America currently dominates due to early adoption while Asia Pacific is poised to grow the fastest owing to expanding healthcare infrastructure and increasing disposable incomes in major countries.
Key players operating in the hyperthermia cancer treatment market are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+, Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System, Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical, Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan. Key players are focusing on introducing innovative combined therapies that leverage thermal effects along with chemotherapy, immunotherapy and radiation. Collaboration with hospitals and cancer centers is another area of focus.
The acceptance of hyperthermia as a complementary treatment is increasing driven by its ability to enhance outcomes when used with other major cancer therapies. Ongoing research aims to expand applications across more cancer types and treatment combinations through precision delivery techniques.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.